Then the Fadu and HN8 cells were treated with BRD4770 following radiation, which showed that inhibition of G9a with BRD4770 enhanced the efficacy of radiotherapy in HNSCC (Fig. 3A, B). The gene discussed is EHMT2; the disease is head and neck squamous cell carcinoma.